Viridian Therapeutics, Inc.(VRDN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRDN Viridian Therapeutics, Inc.

盘前交易 02-20 06:41:09 EST

28.10

-0.01

-0.04%

最高28.60	最低27.41	成交量155.74万
今开28.01	昨收28.11	日振幅4.23%
总市值26.82亿	流通市值22.68亿	总股本9,544万
成交额4,351万	换手率1.93%	流通股本8,072万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRDN","market":"US","secType":"STK","nameCN":"Viridian Therapeutics, Inc.","latestPrice":28.1,"timestamp":1771534800000,"preClose":28.11,"halted":0,"volume":1557448,"delay":0,"changeRate":-0.0003557452863748848,"floatShares":80723000,"shares":95442008,"eps":-3.020489,"marketStatus":"盘前交易","change":-0.01,"latestTime":"02-20 06:41:09 EST","open":28.01,"high":28.595,"low":27.405,"amount":43505824.074608,"amplitude":0.042334,"askPrice":28.25,"askSize":100,"bidPrice":28,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.020489,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771597800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":28.1,"postHourTrading":{"tag":"盘后","latestPrice":27.56,"preClose":28.1,"latestTime":"19:58 EST","volume":123669,"amount":3474050.61,"timestamp":1771549089350,"change":-0.54,"changeRate":-0.019217,"amplitude":0.039146},"volumeRatio":1.2057260122047078,"impliedVol":1.187,"impliedVolPercentile":0.952},"requestUrl":"/m/hq/s/VRDN/tweets","defaultTab":"tweets","newsList":[{"id":"1115352852","title":"Viridian Therapeutics成功向美国FDA提交了Veligrotug治疗甲状腺眼病的生物许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1115352852","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115352852?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:01","pubTimestamp":1762171293,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics成功于10月向美国FDA提交了Veligrotug治疗甲状腺眼病的生物许可申请。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VRDN"],"gpt_icon":0},{"id":"1111350787","title":"Viridian Therapeutics宣布2.51亿美元普通股公开发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1111350787","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111350787?lang=zh_cn&edition=full","pubTime":"2025-10-22 11:38","pubTimestamp":1761104305,"startTime":"0","endTime":"0","summary":"10月21日 - Viridian Therapeutics Inc：*Viridian Therapeutics宣布2.51亿美元普通股公开发行定价*Viridian Therapeutics Inc：计划以每股22美元的价格出售总计1140万股普通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VRDN"],"gpt_icon":0},{"id":"1138514848","title":"Viridian Therapeutics, Inc.: 出售共计1140万股普通股，价格为每股22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138514848","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138514848?lang=zh_cn&edition=full","pubTime":"2025-10-22 11:25","pubTimestamp":1761103510,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics, Inc.: 出售共计1140万股普通股，价格为每股22美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VRDN"],"gpt_icon":0},{"id":"1101026649","title":"Viridian Therapeutics - 融资收益预计将完全支持Veligrotug和Vrdn-003的商业发布","url":"https://stock-news.laohu8.com/highlight/detail?id=1101026649","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101026649?lang=zh_cn&edition=full","pubTime":"2025-10-20 19:33","pubTimestamp":1760959987,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics - 融资收益预计将完全支持Veligrotug和Vrdn-003的商业发布","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRDN","BK4139"],"gpt_icon":0},{"id":"1163051048","title":"Viridian Therapeutics宣布两项Reveal临床试验完成入组并公布积极的投资组合更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1163051048","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163051048?lang=zh_cn&edition=full","pubTime":"2025-09-15 19:01","pubTimestamp":1757934084,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics宣布两项Reveal临床试验完成入组并公布积极的投资组合更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VRDN"],"gpt_icon":0},{"id":"1109883220","title":"异动解读 | 生物制药公司Viridian Therapeutics盘中大涨5.01% 潜在疗效获看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1109883220","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109883220?lang=zh_cn&edition=full","pubTime":"2025-03-07 04:26","pubTimestamp":1741292806,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics Inc.(VRDN)今日盘中股价大涨5.01%,引发市场关注。该公司是一家临床阶段的生物制药公司,主攻肿瘤和罕见疾病的治疗药物开发。\n据了解,Viridian的候选产品VRDN-001是一种抗IGF-1R单克隆抗体,目前正在开发用于治疗甲状腺眼病患者。市场分析人士认为,如果该产品临床试验取得成功,将会大幅改善甲状腺眼病患者的生活质量,因此备受市场关注和期待。\n不过,目前VRDN-001仍处于临床试验阶段,未来能否最终获批上市还有待进一步数据验证。但该产品的潜在疗效已获资本市场初步认可,或是推动Viridian今日股价大涨的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 生物制药公司Viridian Therapeutics盘中大涨5.01% 潜在疗效获看好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VRDN"],"gpt_icon":0},{"id":"2510335800","title":"Viridian Therapeutics, Inc.盘中异动 早盘股价大跌5.06%报17.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510335800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510335800?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:21","pubTimestamp":1739287319,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时21分，Viridian Therapeutics, Inc.股票出现波动，股价急速下挫5.06%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.62%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2577.70%、890.43%、345.86%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为52.11%、47.30%、37.99%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232159a242067a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232159a242067a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRDN","BK4139","LENZ"],"gpt_icon":0},{"id":"2509205872","title":"Viridian Therapeutics, Inc.盘中异动 早盘急速下跌5.04%报18.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509205872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509205872?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:45","pubTimestamp":1738856717,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时45分，Viridian Therapeutics, Inc.股票出现异动，股价大幅跳水5.04%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为5552.09%、1348.99%、134.42%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Azitra Inc、Transcode Therapeutics, Inc.，振幅分别为103.10%、42.43%、39.93%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234517abc4e50f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234517abc4e50f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRDN","LENZ","BK4139"],"gpt_icon":0},{"id":"2507326670","title":"Viridian Therapeutics, Inc.盘中异动 下午盘快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507326670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507326670?lang=zh_cn&edition=full","pubTime":"2025-01-31 04:07","pubTimestamp":1738267662,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日04时07分，Viridian Therapeutics, Inc.股票出现波动，股价急速上涨5.04%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Dominari Holdings Inc.涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1811.25%、328.69%、253.86%，振幅较大的相关个股有Dominari Holdings Inc.、Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为70.55%、65.98%、64.10%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131040743a2348d3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131040743a2348d3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VRDN"],"gpt_icon":0},{"id":"2505272140","title":"Viridian Therapeutics, Inc.盘中异动 早盘快速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505272140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505272140?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:52","pubTimestamp":1737471141,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时52分，Viridian Therapeutics, Inc.股票出现波动，股价快速拉升5.05%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。其相关个股中，Channel Therapeutics Corporation、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Dogwood Therapeutics, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Dermata Therapeutics, Inc.、Channel Therapeutics Corporation较为活跃，换手率分别为633.15%、167.99%、126.52%，振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Atara Biotherapeutics, Inc.，振幅分别为92.63%、38.48%、17.50%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225221960bbdc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225221960bbdc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRDN","LENZ","BK4139"],"gpt_icon":0},{"id":"2504160739","title":"Viridian Therapeutics, Inc.盘中异动 早盘股价大涨5.04%报17.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504160739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504160739?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:13","pubTimestamp":1737126785,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时13分，Viridian Therapeutics, Inc.股票出现异动，股价快速拉升5.04%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Silexion Therapeutics Corp、Aeon Biopharma, Inc.较为活跃，换手率分别为148.90%、22.45%、21.81%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为51.37%、47.91%、43.71%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117231305a225c4ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117231305a225c4ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VRDN"],"gpt_icon":0},{"id":"2503642073","title":"Viridian Therapeutics, Inc.盘中异动 急速拉升5.46%报17.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503642073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503642073?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951470,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分，Viridian Therapeutics, Inc.股票出现异动，股价快速上涨5.46%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Os Therapies Incorporated、Generation Bio Co.、Exicure, Inc.涨幅较大，Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃，换手率分别为184.25%、56.33%、51.74%，振幅较大的相关个股有Os Therapies Incorporated、Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为18.99%、12.00%、10.72%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152231109604b39f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152231109604b39f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRDN","BK4139","LENZ"],"gpt_icon":0},{"id":"2503635703","title":"Viridian Therapeutics, Inc.盘中异动 急速下跌5.15%报16.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503635703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503635703?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:18","pubTimestamp":1736885933,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时18分，Viridian Therapeutics, Inc.股票出现波动，股价快速下挫5.15%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.29%。其相关个股中，Eterna Therapeutics Inc.、Xortx Therapeutics Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为1086.85%、606.13%、422.02%，振幅较大的相关个股有Eterna Therapeutics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Matinas Biopharma Holdings, Inc.，振幅分别为170.74%、146.24%、69.81%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011504185398663b26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011504185398663b26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRDN","LENZ","BK4139"],"gpt_icon":0},{"id":"2502870571","title":"Viridian Therapeutics, Inc.盘中异动 快速跳水5.12%报19.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502870571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502870571?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:29","pubTimestamp":1736357357,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日01时29分，Viridian Therapeutics, Inc.股票出现异动，股价快速下挫5.12%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、Nls Pharmaceutics Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3430.72%、595.71%、588.03%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为192.73%、143.11%、89.00%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012917a21a7a84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012917a21a7a84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VRDN","LENZ"],"gpt_icon":0},{"id":"2501781493","title":"Viridian Therapeutics, Inc.盘中异动 大幅拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501781493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501781493?lang=zh_cn&edition=full","pubTime":"2025-01-08 00:04","pubTimestamp":1736265883,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日00时04分，Viridian Therapeutics, Inc.股票出现波动，股价快速上涨5.26%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。其相关个股中，Hoth Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc.涨幅较大，Hoth Therapeutics, Inc.、Immuneering Corporation、Scisparc Ltd.较为活跃，换手率分别为4015.87%、224.82%、139.54%，振幅较大的相关个股有Hoth Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alpha Tau Medical Ltd C/Wts ，振幅分别为287.95%、86.33%、61.67%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108000443985e246f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108000443985e246f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRDN","BK4139","LENZ"],"gpt_icon":0},{"id":"2492398180","title":"Viridian Therapeutics, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492398180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492398180?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:21","pubTimestamp":1734535297,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日23时21分，Viridian Therapeutics, Inc.股票出现波动，股价快速跳水5.13%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为2163.27%、437.93%、286.02%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为227.62%、115.61%、66.83%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218232137984cb39f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218232137984cb39f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VRDN"],"gpt_icon":0},{"id":"2491720694","title":"Viridian Therapeutics, Inc.股价拉升17.42% 市值涨2.89亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491720694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491720694?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:31","pubTimestamp":1734359489,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时31分，Viridian Therapeutics, Inc.股票出现异动，股价急速拉升17.42%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Tonix Pharmaceuticals Holding Corp.、Viridian Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.、Genprex, Inc.较为活跃，换手率分别为29.04%、27.45%、20.41%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、X4制药、Aprea Therapeutics, Inc.，振幅分别为5.74%、5.70%、5.63%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223129a1f34292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223129a1f34292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VRDN"],"gpt_icon":0},{"id":"2491550373","title":"Viridian Therapeutics, Inc.盘中异动 下午盘股价大跌5.09%报18.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491550373","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491550373?lang=zh_cn&edition=full","pubTime":"2024-12-13 03:04","pubTimestamp":1734030294,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日03时04分，Viridian Therapeutics, Inc.股票出现异动，股价大幅下跌5.09%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.13%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Trevi Therapeutics, Inc.、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为4033.92%、1179.70%、93.49%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Aptevo Therapeutics Inc.，振幅分别为129.16%、99.29%、95.90%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121303045495e94023&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121303045495e94023&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VRDN","BK4139"],"gpt_icon":0},{"id":"2486776884","title":"Viridian Therapeutics, Inc.盘中异动 急速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486776884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486776884?lang=zh_cn&edition=full","pubTime":"2024-11-27 02:06","pubTimestamp":1732644383,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日02时06分，Viridian Therapeutics, Inc.股票出现波动，股价大幅拉升5.18%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Poseida Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd、Cardio Diagnostics Holdings Inc.涨幅较大，Elevai Labs, Inc.、木薯科学、Tc Biopharm  Plc较为活跃，换手率分别为48.09%、43.59%、30.36%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Lakeshore Biopharma Co., Ltd，振幅分别为85.82%、57.50%、55.39%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127020623abe11a6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127020623abe11a6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VRDN","LENZ"],"gpt_icon":0},{"id":"2486261038","title":"Viridian Therapeutics, Inc.盘中异动 早盘大幅拉升5.02%报21.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486261038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486261038?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545209,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，Viridian Therapeutics, Inc.股票出现异动，股价大幅拉升5.02%。Viridian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为86.95%、61.09%、38.36%，振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc，振幅分别为105.47%、105.26%、105.01%。Viridian Therapeutics, Inc.公司简介：Viridian Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发多种候选产品，治疗甲状腺眼病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522332998e44655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522332998e44655&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRDN","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.viridiantherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0226},{"period":"1month","weight":-0.1391},{"period":"3month","weight":-0.0738},{"period":"6month","weight":0.4616},{"period":"1year","weight":0.6948},{"period":"ytd","weight":-0.097}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.1167},{"period":"ytd","weight":0.0038}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Viridian Therapeutics, Inc.于2014年6月17日在特拉华州成立，该公司是一家生物制药公司，专注于研究和开发针对严重和罕见疾病的潜在最佳药物。该公司瞄准的是竞争不激烈的疾病领域，在这些领域，已上市的疗法往往为提高疗效、安全性或给药便利性留出空间。该公司认为，第一代药物很少代表最佳解决方案，特别是在罕见病领域，而且有潜力开发差异化、同类最佳的药物，从而改善患者的治疗效果、减少副作用、提高生活质量、扩大市场准入和加强市场竞争。该公司正在开发三种候选产品：VRDN-001、VRDN-002和VRDN-003，这些产品正在开发中，用于静脉注射或皮下注射，以治疗患有甲状腺眼病（TED）的患者。该公司最先进的项目VRDN-001是一种靶向IGF-1R的差异化人源化单克隆抗体，用于治疗TED。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.269131},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.086418},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.079972},{"month":4,"riseRate":0.636364,"avgChangeRate":0.028562},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.019028},{"month":6,"riseRate":0.545455,"avgChangeRate":0.005985},{"month":7,"riseRate":0.5,"avgChangeRate":0.010016},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.082663},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.012515},{"month":10,"riseRate":0.25,"avgChangeRate":-0.0411},{"month":11,"riseRate":0.583333,"avgChangeRate":0.157254},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.069844}],"exchange":"NASDAQ","name":"Viridian Therapeutics, Inc.","nameEN":"Viridian Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Viridian Therapeutics, Inc.(VRDN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Viridian Therapeutics, Inc.(VRDN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Viridian Therapeutics, Inc.,VRDN,Viridian Therapeutics, Inc.股票,Viridian Therapeutics, Inc.股票老虎,Viridian Therapeutics, Inc.股票老虎国际,Viridian Therapeutics, Inc.行情,Viridian Therapeutics, Inc.股票行情,Viridian Therapeutics, Inc.股价,Viridian Therapeutics, Inc.股市,Viridian Therapeutics, Inc.股票价格,Viridian Therapeutics, Inc.股票交易,Viridian Therapeutics, Inc.股票购买,Viridian Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Viridian Therapeutics, Inc.(VRDN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Viridian Therapeutics, Inc.(VRDN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}